Cambridge-based developer King Street Properties’ bet on Framingham’s potential to attract more life science companies has paid off with an anchor lease by a Woburn firm that recently filed for a $100 million initial public offering.

Replimune Group Inc. signed a 10-year lease for 63,278 square feet at 33 New York Ave., the former MetroWest Daily News building, according to a filing with the Middlesex County Registry of Deeds.

King Street acquired the nearly 100,000-square-foot office and printing facility in February from GateHouse Media for $9.3 million. The Daily News moved to 1 Speen St. in late 2017. Replimune’s lease is scheduled to take effect Nov. 30.

The clinical-stage cancer researchers raised $55 million in series B venture capital financing in September and recently filed for a $100 million initial public offering.

King Street Properties Principal Thomas Ragno in an April interview said the Framingham property was attracting “strong interest” among biomanufacturing and lab tenants. King Street is renovating the one-story Framingham building and expanding it by 9,000 square feet.

King Street Properties has been focusing on the West Cambridge and Route 128 markets as growth zones for life science space, including a $45.5 million speculative office and lab building at 115 Hartwell Ave. in Lexington completed last year, which is 100 percent leased.

And in a joint venture with Carlyle Group, it’s developing a $75 million, 144,910-square-foot speculative office and lab building at 828 Winter St. in Waltham, which is scheduled for completion this month.